
Operio Group, LLC
Global manufacturer of tablet, capsule, and ingredient machinery for the pharmaceutical, nutraceutical, and food industries. At its peak, $90M+ revenue · 220+ employees · 9 international locations. In 2026 Operio divested its operating businesses. Alastair oversaw the sale process and then the structured wind-down of the holding company.





